Literature DB >> 31007865

Biomedical applications of mRNA nanomedicine.

Qingqing Xiong1,2, Gha Young Lee1, Jianxun Ding1, Wenliang Li1,3, Jinjun Shi1.   

Abstract

As an attractive alternative to plasmid DNA, messenger RNA (mRNA) has recently emerged as a promising class of nucleic acid therapeutics for biomedical applications. Advances in addressing the inherent shortcomings of mRNA and in the development of nanoparticle-based delivery systems have prompted the development and clinical translation of mRNA-based medicines. In this review, we discuss the chemical modification strategies of mRNA to improve its stability, minimize immune responses, and enhance translational efficacy. We also highlight recent progress in nanoparticle-based mRNA delivery. Considerable attention is given to the increasingly widespread applications of mRNA nanomedicine in the biomedical fields of vaccination, protein-replacement therapy, gene editing, and cellular reprogramming and engineering.

Entities:  

Keywords:  cellular reprogramming; chemical modification; engineering; gene editing; messenger RNA; nanoparticle; protein-replacement; vaccination

Year:  2018        PMID: 31007865      PMCID: PMC6472920          DOI: 10.1007/s12274-018-2146-1

Source DB:  PubMed          Journal:  Nano Res        ISSN: 1998-0000            Impact factor:   8.897


  22 in total

1.  Synthetic mRNA nanoparticle-mediated restoration of p53 tumor suppressor sensitizes p53-deficient cancers to mTOR inhibition.

Authors:  Na Kong; Wei Tao; Xiang Ling; Junqing Wang; Yuling Xiao; Sanjun Shi; Xiaoyuan Ji; Aram Shajii; Silvia Tian Gan; Na Yoon Kim; Dan G Duda; Tian Xie; Omid C Farokhzad; Jinjun Shi
Journal:  Sci Transl Med       Date:  2019-12-18       Impact factor: 17.956

2.  Formulation and Delivery Technologies for mRNA Vaccines.

Authors:  Chunxi Zeng; Chengxiang Zhang; Patrick G Walker; Yizhou Dong
Journal:  Curr Top Microbiol Immunol       Date:  2020-06-02       Impact factor: 4.291

Review 3.  RNA delivery biomaterials for the treatment of genetic and rare diseases.

Authors:  Weiyu Zhao; Xucheng Hou; Olivia G Vick; Yizhou Dong
Journal:  Biomaterials       Date:  2019-06-20       Impact factor: 12.479

4.  Construction of Messenger RNA (mRNA) Probes Delivered By Lipid Nanoparticles to Visualize Intracellular Protein Expression and Localization at Organelles.

Authors:  Weiyu Zhao; Chunxi Zeng; Jingyue Yan; Shi Du; Xucheng Hou; Chengxiang Zhang; Wenqing Li; Binbin Deng; David W McComb; Yonger Xue; Diana D Kang; Yizhou Dong
Journal:  Adv Mater       Date:  2021-09-20       Impact factor: 32.086

Review 5.  Biomaterials-Mediated Tumor Infarction Therapy.

Authors:  Shizheng Tong; Wei Zhao; Duoyi Zhao; Weilin Zhang; Zhiyu Zhang
Journal:  Front Bioeng Biotechnol       Date:  2022-06-09

6.  Reactivation of the tumor suppressor PTEN by mRNA nanoparticles enhances antitumor immunity in preclinical models.

Authors:  Yao-Xin Lin; Yi Wang; Jianxun Ding; Aiping Jiang; Jie Wang; Mian Yu; Sara Blake; Shuaishuai Liu; Charles J Bieberich; Omid C Farokhzad; Lin Mei; Hao Wang; Jinjun Shi
Journal:  Sci Transl Med       Date:  2021-06-23       Impact factor: 17.956

7.  Arginine-Based Poly(I:C)-Loaded Nanocomplexes for the Polarization of Macrophages Toward M1-Antitumoral Effectors.

Authors:  Tamara G Dacoba; Clément Anfray; Francesco Mainini; Paola Allavena; María José Alonso; Fernando Torres Andón; José Crecente-Campo
Journal:  Front Immunol       Date:  2020-07-07       Impact factor: 7.561

8.  Long-term storage of lipid-like nanoparticles for mRNA delivery.

Authors:  Pengxuan Zhao; Xucheng Hou; Jingyue Yan; Shi Du; Yonger Xue; Wenqing Li; Guangya Xiang; Yizhou Dong
Journal:  Bioact Mater       Date:  2020-03-18

Review 9.  Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives.

Authors:  Itziar Gómez-Aguado; Julen Rodríguez-Castejón; Mónica Vicente-Pascual; Alicia Rodríguez-Gascón; María Ángeles Solinís; Ana Del Pozo-Rodríguez
Journal:  Nanomaterials (Basel)       Date:  2020-02-20       Impact factor: 5.076

Review 10.  RNA Nanotechnology-Mediated Cancer Immunotherapy.

Authors:  Yao-Xin Lin; Yi Wang; Sara Blake; Mian Yu; Lin Mei; Hao Wang; Jinjun Shi
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.